Trial intelligence / Profile preview

Levofloxacin Prophylaxis for BK Virus in Kidney Transplant

NCT01353339Phase 4Completed

Sponsor
Ottawa Hospital Research Institute
Start
Dec 2011
Primary completion
Feb 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of levofloxacin in BK virus infection, sponsored by Ottawa Hospital Research Institute. Started Dec 2011; status: completed.

02

Drugs

levofloxacin
03

Conditions

BK virus infection

Beyond the preview

Go deeper on NCT01353339.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01353339.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call